fbpx
  • Home
  • Cannabinoids 101
  • Episodes
  • Medical Cannabis
Cannabinoid Connect
  • NEWSLETTER
  • About
  • Contact Us
Login / Register
Search
Wishlist
0 items / $0.00
Menu
Cannabinoid Connect
0 items $0.00

Tag Archives: psychedelics

HomePosts Tagged "psychedelics"
Cannabinoid Connect 358: Ruby Deevoy, Cannabis & Psychedelics Journalist
09 Feb
Education, Government Policy and Legislation, Industry News and Trends, Medical Cannabis

#358: UK Journalist Ruby Deevoy on the United Kingdom’s medical cannabis and psychedelics industry

  • February 9, 2023
  • By author-avatar Kevin
Ruby Deevoy is one of the UK’s very few dedicated cannabis and CBD journalists, contributing regularly on the subject to international ...

Continue reading

Cannabinoid Connect 347: Paul Weaver and Seng Robertson, The Boston Beer Company
20 Dec
Infused Beverages

#347: Paul Weaver and Seng Robertson on Boston Beer Co. testing THC-infused drinks in the Canadian Market

  • December 20, 2022
  • By author-avatar Kevin
Paul Weaver is the Head of Cannabis and Seng Robertson is the Technical Director of Cannabis Research and Development at Boston Beer Co...

Continue reading

Cannabinoid Connect 346: Shelby Hartman, DoubleBlind Magazine
15 Dec
Industry News and Trends, Psychedelics, Spirituality & Higher Consciousness

#346: DoubleBlind’s Shelby Hartman on tapping into therapeutic and spiritual seekerdom with informative content

  • December 15, 2022
  • By author-avatar Kevin
Shelby Hartman is the Co-Founder and CEO of DoubleBlind, a media company and education platform at the forefront of the rapidly growing...

Continue reading

Cannabinoid Connect 303: Dustin Robinson, Mr. Cannabis Law, Mr. Psychedelic Law, & Iter Investments
09 Jun
Psychedelics, Technology Solutions and Trends

#303: Dustin Robinson, Mr. Cannabis Law, Mr. Psychedelic Law, & Iter Investments

  • June 9, 2022
  • By author-avatar Kevin
Dustin Robinson is the Founding partner of Mr. Cannabis Law; Co-Founder of Mr. Psychedelic Law; Managing Principal of Iter Investments;...

Continue reading

Cannabinoid Connect 222: Tim Schlidt, Palo Santo
17 Sep
Health/Science/Wellness, Psychedelics

#222: Tim Schlidt, Palo Santo

  • November 25, 2021
  • By author-avatar Kevin
Tim Schlidt is the Co-Founder and Partner at Palo Santo, the leading U.S.-based psychedelic investment fund. Topics Discussed: ...

Continue reading

Cannabinoid Connect 163: Rob Davidson, CURE Pharmaceutical
09 Apr
Health/Science/Wellness, Psychedelics, Technology Solutions and Trends

#163: Rob Davidson, CURE Pharmaceutical

  • November 25, 2021
  • By author-avatar Kevin
Rob Davidson is the CEO at CURE Pharmaceutical, pioneering developer of CUREform™, a patented drug delivery platform that offers a numb...

Continue reading

Cannabinoid Connect #100: Ty Burgess, One Biosciences
11 Jan
Health/Science/Wellness, Psychedelics

#100: Ty Burgess, One Biosciences

  • November 25, 2021
  • By author-avatar Kevin
Ty Burgess is the CEO at One Biosciences, a "whole person wellness" company that focuses on combining both science and nature to delive...

Continue reading

Cannabinoid Connect #34: Steven Gottlieb, Plant Medicine Practitioner
21 Aug
Health/Science/Wellness, Lifestyle and Consumption Methods, Psychedelics

#34: Steven Gottlieb, Plant Medicine Practitioner

  • November 25, 2021
  • By author-avatar Kevin
Steven Gottlieb is a Plant Medicine Practitioner who focuses on Ibogaine treatment for addiction, PTSD, and other mental illnesses. ...

Continue reading

Disclaimer:  This product is not for use by or sale to persons under the age of 18.  This product should be use only as directed on the label.  It should not be used if you are pregnant or nursing.  Consult with a physician before use if you have a serious medical condition or use prescription medications.  A Doctor’s advice should be sought before using this and any supplemental dietary product.  All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product.  These statements have not been evaluated by the FDA.  This product is not intended to diagnose, treat, cure or prevent any disease. [COMPANY NAME] certifies that the delta-9 tetrahydrocannabinol (“THC”) concentration of this product is not more than 0.3%.  By using this site, you agree to follow the Terms and Conditions and Privacy Policy printed on this site.  Void Where Prohibited by Law.

The nation’s most diverse cannabis podcast.

kevin@cannabinoid-connect.com
Useful links
  • Privacy Policy
  • Terms & Conditions
  • Return Policy
  • Contact Us
  • Latest Episodes
Recent Podcasts
  • Cannabinoid Connect 412: Barron Lutz, Nasha Hash
    #412: The Art & Science of Hash: Barron Lutz on Solventless Extraction, Genetics & Quality
    March 13, 2025 No Comments
  • Cannabinoid Connect 411: Rama Mayo, Hall of Flowers
    #411: How Cannabis Brands Win: The Power of Storytelling, Authenticity & Experience
    February 26, 2025 No Comments
CANNABINOID CONNECT 2021 - All Rights Reserved.
payments
Start typing to see products you are looking for.
  • Home
  • Cannabinoids 101
  • Medical Cannabis
  • Episodes
  • About
  • Contact Us
  • BECOME A SPONSOR
  • RECOMMEND A GUEST
  • Wishlist
  • Compare
  • Login / Register
Shopping cart
Close
Sign in
Close

Lost your password?

No account yet?

Create an Account

Will be used in accordance with our Privacy Policy

Are you over 18?

You must be 18 years of age or older to view page. Please verify your age to enter.

Access forbidden

Your access is restricted because of your age.

I am 18 or Older I am Under 18